-
Post-COVID condition in patients with inflammatory rheumatic diseases: a prospective cohort study in the Netherlands
Boekel, L., Atiqi, S., Leeuw, M., Hooijberg, F., Besten, Y. R., Wartena, R., Steenhuis, M., Vogelzang, E., Webers, C., Boonen, A., Gerritsen, M., Lems, W. F., Tas, S. W., van Vollenhoven, R. F., Voskuyl, A. E., van der Horst-Bruinsma, I., Nurmohamed, M., Rispens, T. & Wolbink, G., 1 Jul 2023, In: The Lancet Rheumatology. 5, 7, p. e375-e385Research output: Contribution to journal › Article › Academic › peer-review
-
SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period
Boekel, L., Besten, Y. R., Hooijberg, F., Wartena, R., Steenhuis, M., Vogelzang, E., Leeuw, M., Atiqi, S., Tas, S. W., Lems, W. F., van Ham, S. M., Eftimov, F., Stalman, E. W., Wieske, L., Kuijpers, T. W., Voskuyl, A. E., van Vollenhoven, R. F., Gerritsen, M., Krieckaert, C., Rispens, T., & 3 others , 1 Nov 2022, In: The Lancet Rheumatology. 4, 11, p. e747-e750 4 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies
T2B! immunity against SARS-CoV-2 study group, 1 Jun 2022, In: The Lancet Rheumatology. 4, 6, p. e417-e429Research output: Contribution to journal › Article › Academic › peer-review
- All publications